Stay updated on GABA-A Targeting in ASD Clinical Trial

Sign up to get notified when there's something new on the GABA-A Targeting in ASD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GABA-A Targeting in ASD Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The site footer revision label changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-22T14:59:25.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the completed FAST-AS study is displayed, describing a Phase 2 trial of AZD7325 versus placebo for adults with autism spectrum disorder. It also provides study eligibility, participating locations, outcomes, and record history.
    Difference
    39%
    Check dated 2026-11-08T14:59:32.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The 403 Forbidden message is gone, and the page shows the ClinicalTrials.gov site shell without visible study details.
    Difference
    0.6%
    Check dated 2026-11-01T16:02:56.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A banner announces the NIH website transition and says that some content may use “Super Intelligence” instead of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T15:16:15.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2; the study record remains behind a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T15:27:00.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T15:13:17.000Z thumbnail image

Stay in the know with updates to GABA-A Targeting in ASD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GABA-A Targeting in ASD Clinical Trial page.